Envestnet Asset Management Inc. Decreases Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Envestnet Asset Management Inc. trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 10.0% in the second quarter, Holdings Channel reports. The firm owned 79,278 shares of the company’s stock after selling 8,822 shares during the period. Envestnet Asset Management Inc.’s holdings in Henry Schein were worth $5,082,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Empirical Finance LLC boosted its position in Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after purchasing an additional 160 shares during the period. Covestor Ltd boosted its position in Henry Schein by 12.8% during the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after purchasing an additional 171 shares during the period. Sequoia Financial Advisors LLC boosted its position in Henry Schein by 3.2% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after purchasing an additional 176 shares during the period. Wahed Invest LLC boosted its position in Henry Schein by 9.2% during the 4th quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock worth $168,000 after purchasing an additional 187 shares during the period. Finally, Crossmark Global Holdings Inc. boosted its position in Henry Schein by 1.5% in the 4th quarter. Crossmark Global Holdings Inc. now owns 13,090 shares of the company’s stock valued at $991,000 after buying an additional 197 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of analyst reports. UBS Group decreased their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Piper Sandler reissued an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. Robert W. Baird decreased their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Barrington Research reissued an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Friday, September 20th. Finally, Evercore ISI decreased their price objective on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $77.10.

Insider Buying and Selling

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.14% of the stock is owned by company insiders.

Henry Schein Stock Performance

Shares of HSIC stock opened at $72.90 on Tuesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The company’s 50-day simple moving average is $70.14 and its 200-day simple moving average is $70.17. The stock has a market capitalization of $9.33 billion, a price-to-earnings ratio of 24.63, a PEG ratio of 2.01 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.10 billion for the quarter, compared to analysts’ expectations of $3.27 billion. During the same quarter last year, the company posted $1.31 earnings per share. The company’s quarterly revenue was up .0% compared to the same quarter last year. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.